03:36 PM EDT, 10/22/2026 (MT Newswires) -- Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index adding 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) gaining 1.4%. The iShares Biotechnology ETF (IBB) fell 1.3%. In corporate news, Gilead Sciences (GILD) agreed to pay $45 million to settle claims by Texas Attorney General Ken Paxton that it engaged in an "illegal kickback scheme that improperly influenced prescriptions" covered by Texas Medicaid, the attorney general said Thursday. Gilead shares were up 2.1%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Data released on Friday showed that Japan’s core Consumer Price Index (CPI) rose by 2.1% year-on-year in September, exceeding the Bank of Japan’s 2% inflation target for the first time in nine months. This indicates that price pressures are spreading and reinforces market expectations of an interest rate hike in the near future.
DoubleLine Capital Deputy Chief Investment Officer Jeffrey Sherman stated that he remains bearish on long-term U.S. Treasury bonds, believing that large-scale government borrowing and weak demand will continue to put pressure on the U.S. Treasury market.